Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 7/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.55 |
| ▸ | MAPT | P10636 | 6/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | HPGD | P15428 | 4/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.47 |
| ▸ | NPC1 | O15118 | 5/20 | 0.47 |
| ▸ | RAB9A | P51151 | 4/20 | 0.47 |
| ▸ | MAOA | P21397 | 4/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.45 |
| ▸ | CASP1 | P29466 | 1/20 | 0.45 |
| ▸ | CASP7 | P55210 | 1/20 | 0.45 |
| ▸ | TTR | P02766 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 3/20 | 0.41 |
| ▸ | HTR2B | P41595 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26342774 | 0.96 | AHR (0.53) | AHRMEN1KMT2AMAPTKDM4E | |
| SCHEMBL26342826 | 0.94 | AHR (0.52) | AHRMEN1KMT2AMAPTKDM4E | |
| SCHEMBL14295300 | 0.94 | AHR (0.52) | AHRMEN1KMT2AMAPTKDM4E | |
| SCHEMBL21968642 | 0.94 | AHR (0.52) | AHRMEN1KMT2AMAPTKDM4E | |
| SCHEMBL24029467 | 0.94 | AHR (0.52) | AHRMEN1KMT2AMAPTKDM4E | |
| SCHEMBL24623784 | 0.94 | AHR (0.52) | AHRMEN1KMT2AMAPTKDM4E | |
| SCHEMBL17720588 | 0.94 | AHR (0.52) | AHRMEN1KMT2AMAPTKDM4E | |
| SCHEMBL31192279 | 0.94 | AHR (0.52) | AHRMEN1KMT2AMAPTKDM4E | |
| SCHEMBL14295294 | 0.93 | AHR (0.50) | AHRMEN1KMT2AMAPTKDM4E | |
| SCHEMBL24199095 | 0.93 | AHR (0.50) | AHRMEN1KMT2AMAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11925111-B2 | Organic light emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-03-05 | — | — | US | disclosed |
| US-11925111-B2 | Organic light emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-03-05 | — | — | US | disclosed |
| US-20240074307-A1 | ORGANIC LIGHT EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-02-29 | — | — | US | disclosed |
| US-20240074307-A1 | ORGANIC LIGHT EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-02-29 | — | — | US | disclosed |
| US-20220029102-A1 | ORGANIC LIGHT EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-01-27 | — | — | US | disclosed |
| US-11145819-B2 | Organic light emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-10-12 | — | — | US | disclosed |
| US-20200321531-A1 | ORGANIC LIGHT EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-10-08 | — | — | US | disclosed |
| US-10734586-B2 | Organic light emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-08-04 | — | — | US | disclosed |
| US-9847491-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-12-19 | — | — | US | disclosed |
| US-9847491-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-12-19 | — | — | US | disclosed |
| US-20120199817-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. | 2012-08-09 | — | — | US | disclosed |
| US-20120199817-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. | 2012-08-09 | — | — | US | disclosed |
| US-20120119197-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | IDEMITSU KOSAN CO., LTD. (JP) | 2012-05-17 | — | — | US | disclosed |
| US-20120119197-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | IDEMITSU KOSAN CO., LTD. (JP) | 2012-05-17 | — | — | US | disclosed |
| US-8106391-B2 | Organic EL device | IDEMITSU KOSAN CO., LTD. (JP) | 2012-01-31 | — | — | US | disclosed |
| US-8106391-B2 | Organic EL device | IDEMITSU KOSAN CO., LTD. (JP) | 2012-01-31 | — | — | US | disclosed |
| US-20100283043-A1 | ORGANIC EL ELEMENT | IDEMITSU LOSAN CO., LTD. | 2010-11-11 | — | — | US | disclosed |
| US-20100283043-A1 | ORGANIC EL ELEMENT | IDEMITSU LOSAN CO., LTD. | 2010-11-11 | — | — | US | disclosed |
| US-20100219404-A1 | ORGANIC EL DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2010-09-02 | — | — | US | disclosed |
| US-20100219404-A1 | ORGANIC EL DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2010-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11145819-B2 | Organic light emitting device | SUN2, CYBA, SLC25A21 | AHR 602/4885MEN1 2470/4885KMT2A 3468/4885 |
| US-20200321531-A1 | ORGANIC LIGHT EMITTING DEVICE | SUN2, CYBA, SLC25A21 | AHR 602/4885MEN1 2470/4885KMT2A 3468/4885 |
| US-20240074307-A1 | ORGANIC LIGHT EMITTING DEVICE | SUN2, CYBA, SLC25A21 | AHR 602/4885MEN1 2470/4885KMT2A 3468/4885 |
| US-20120199817-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | FTO, EML4, SLC43A1 | AHR 1951/4885MEN1 1843/4885KMT2A 1408/4885 |
| US-11925111-B2 | Organic light emitting device | SUN2, CYBA, SLC25A21 | AHR 602/4885MEN1 2470/4885KMT2A 3468/4885 |
| US-20220029102-A1 | ORGANIC LIGHT EMITTING DEVICE | SUN2, CYBA, SLC25A21 | AHR 602/4885MEN1 2470/4885KMT2A 3468/4885 |
| US-10734586-B2 | Organic light emitting device | SUN2, CYBA, SLC25A21 | AHR 602/4885MEN1 2470/4885KMT2A 3468/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.